The Limited Times

Now you can see non-English news...

FDA Approves Pfizer Booster Vaccine for High-Risk Individuals

2021-09-23T04:37:24.874Z

The extra dose was not authorized for the entire population but only for those over 65 or more vulnerable to the virus. It is recommended to apply it six months after the first one.



The Federal Food and Drug Administration (FDA) on Wednesday authorized the booster dose of Pfizer-BioNTech for people 65 and older and those who are at high risk for serious illness

at least six months after their second dose.

Those who may suffer a severe coronavirus infection or who are at high risk of contagion from being more exposed to the virus are considered to be at high risk.  

[We answer 5 key questions about the coronavirus vaccine booster]

Loida Méndez, 86, receives the first dose of Pfizer's COVID-19 vaccine from US Army physician Luis Pérez, at a FEMA vaccination center at Miami Dade College in North Miami, Florida.Marta Lavandier / AP

The authorization leads to what will likely be a nationwide campaign to administer vaccines, starting with the most vulnerable population groups.

This can allow tens of millions of already immunized people to receive boosters at pharmacies, health clinics, doctor's offices, and other places.

The agency's decision comes days after an FDA panel of experts made a similar recommendation on the need for a booster dose to the most vulnerable, but

not to the general population

.

More information shortly ...

Source: telemundo

All news articles on 2021-09-23

Similar news:

You may like

News/Politics 2021-09-24T10:08:09.498Z
News/Politics 2021-08-12T02:13:57.762Z
News/Politics 2021-09-16T16:24:00.321Z

Trends 24h

News/Politics 2021-10-13T19:21:02.510Z

Latest

© Communities 2019 - Privacy